跳转至内容
Merck
CN
所有图片(1)

文件

444145

Sigma-Aldrich

MDM2 Inhibitor

The MDM2 Inhibitor, also referenced under CAS 562823-84-1, controls the biological activity of MDM2.

登录查看公司和协议定价

别名:
MDM2 Inhibitor, trans-4-Iodo, 4ʹ-boranyl-chalcone, MDM2 Antagonist IV
经验公式(希尔记法):
C15H12BIO3
分子量:
377.97
UNSPSC代码:
12352200

质量水平

检测方案

≥95% (HPLC)

形式

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

pale yellow

溶解性

DMSO: 10 mg/mL

运输

ambient

储存温度

2-8°C

InChI

1S/C15H12BIO3/c17-14-8-1-11(2-9-14)3-10-15(18)12-4-6-13(7-5-12)16(19)20/h1-10,19-20H/b10-3+

InChI key

BYMGWCQXSPGCMW-XCVCLJGOSA-N

一般描述

A cell-permeable boranyl-chalcone compound that binds strongly to MDM2 and irreversibly disrupts MDM2/p53 protein complex formation. Exhibits selective toxicity to MDM2-overexpressing human breast cancer cell lines (IC50 = 10 µM for MDA-MB-435, 8.8 µM for MDA-MB-231, and 7 µM for Wt-MCF7) compared to normal breast cell lines (IC50 = 75 µM for MCF-10A and 63 µM for MCF-12A).
A cell-permeable boranyl-chalcone that binds strongly to MDM2 and irreversibly disrupts MDM2/p53 protein complex. Exhibits selective toxicity towards MDM2 overexpressing human breast cancer cell lines (IC50 = 10, 8.8, and 7 µM for MDA-MB-435, MDA-MB-231, and Wt-MCF7, respectively) compared to normal breast cell lines (IC50 = 75 and 63 µM for MCF-10A and MCF-12A, respectively).

生化/生理作用

Cell permeable: yes
Primary Target
MDM2
Product does not compete with ATP.
Reversible: no
Target IC50: 10, 8.8, and 7 µM in selective toxicity for MDA-MB-435, MDA-MB-231, and Wt-MCF7, respectively

包装

Packaged under inert gas

警告

Toxicity: Carcinogenic / Teratogenic (D)

重悬

Following reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

其他说明

Kumar, S.K., et al. 2003. J. Med. Chem.46, 2813.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Srinivas K Kumar et al.
Journal of medicinal chemistry, 46(14), 2813-2815 (2003-06-27)
A series of boronic-chalcone derivatives were synthesized and tested for antitumor activity against human breast cancer cell lines. The results show the boronic-chalcones are more toxic to breast cancer cells compared to normal breast cells than other known chalcones.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门